American Pharmacists Association (APhA)
FDANonrulemakingFDA-2012-N-0171

Using Innovative Technologies and Other Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription

RIN
Last modified
Jan 22, 2013
Comment window
closed 5195d ago
American Pharmacists Association (APhA) filings
1

Activity

American Pharmacists Association (APhA) filed 1 comment on this docket between May 15, 2012 and May 15, 2012. 21 other organizations filed here. The comment window closed 5195d ago.

What American Pharmacists Association (APhA) filed (1)

May 15, 2012· American Pharmacists Association (APhA) - Comment· FDA-2012-N-0171-0107

APhA comments to FDA on Potential New Drug Paradigm and Conditions of Safe Use. Attachments Include: *APhA Testimony at March 22, 2012 FDA Public Hearing *APhA Drug Safety Continuum Visual *Additional APhA and APhA Foundation Information *HHS 2010 Letter to APhA in Support of Immunizations

Abstract

No abstract recorded.

View on regulations.gov →